BioVie signs at-the-market equity sales agreement for up to $6.46 million Class A shares

• BioVie entered an at-the-market sales agreement with A.G.P./Alliance Global Partners to sell up to $6.46 million of Class A common stock.
• Shares may be sold from time to time on Nasdaq or in negotiated transactions, with sales paced to market conditions.
• A.G.P. will receive a 3% commission on gross proceeds; BioVie will also reimburse certain agent expenses.
• Proceeds are earmarked for general corporate purposes.
• The program ends once the full amount is sold, the shelf registration expires, or either party terminates the agreement.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioVie Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001520138-26-000391), on September 14, 2026, and is solely responsible for the information contained therein.